1 min
Bruno Larvol, Founder and CEO of Larvol - Preview 1 Personalized Diagnostics
-
- Medicine
Since the human genome has been sequenced, it has become clear that the technology to sequence has far outstripped our capabilities to accurately classify and interpret genetic variants.
It turns out that genetic variants are much more common than we ever suspected and many - in some cases most - variants are of uncertain significance.
But is the attempt to accurately classify Variants of Uncertain Significance (VUS) a losing strategy?
Since the human genome has been sequenced, it has become clear that the technology to sequence has far outstripped our capabilities to accurately classify and interpret genetic variants.
It turns out that genetic variants are much more common than we ever suspected and many - in some cases most - variants are of uncertain significance.
But is the attempt to accurately classify Variants of Uncertain Significance (VUS) a losing strategy?
1 min